Myanmar pharmaceutical market pdf. 1 Overview of Myanmar Pharmaceutical Industry 21 3.

Myanmar pharmaceutical market pdf. Online Retail Segment: The pharmaceuticals eCommerce market in Myanmar is expected to reach USD 23. 9B20A016 SARVA PHARMACEUTICALS: INTERNATIONAL EXPANSION TO MYANMAR Sandeep Blue Sky Co. Pacific Medical Industries, a subsidiary of Pacific AA Group, stands as Myanmar's premier and first private pharmaceutical manufacturing facility, setting the standard for excellence in the industry. The pharma market in India is expected to grow by over a 10 percent compound annual growth rate in the coming three to five years. The Terms of Reference were to examine medicines in health care delivery with respect to medicines supply, selection, use, regulation and policy. 30 billion by 2031 with a CAGR of 7. 3 hours ago · Myanmar authorities are racing to build a field hospital in the commercial capital of Yangon to cope with a surge of coronavirus infections that doctors fear threatens to overwhelm the country's Thida Aye* and James Finch** This article considers the National Drug Law, 1992, of Myanmar or Burma. However, the market is still underweight because of low healthcare spend per capita with a high out-of-pocket component. Market surveillance and control (MC) ntrol of impor- tation, market surveillance program for quality control of products during their supp y-chain, promotion and advertising control and response activities for substan-dard and falsified pharmaceutical products. It was agreed that the WHO/SEARO workbook tool would be used and that a team of government officials, led by the Essential Drug Program of the Medical Care Pharmaceuticals market is predicted to cross US$ 2,840. The Myanmar Pharmaceuticals Market faces several challenges, including a lack of regulatory enforcement leading to counterfeit and substandard drugs entering the market, limited access to healthcare services in rural areas, and a reliance on imported pharmaceutical products due to underdeveloped local manufacturing capabilities. 12% from 2025 to 2030 DSpace - iris. 1 Back ground of the Ministry Industry 17 3. Myanmar people Food Control Activities – in line with policy guidelines from Ministry of Health, Myanmar Food and Drug Board of Authority and implemented according to National Food Law Pre-market assessment - conducted for locally produced food and imported ones and also for exported food Founded in 2014, Htat Thiha Paing Company Limited is a privately held company primarily focused on importation, marketing and distribution of pharmaceutical and healthcare products in Myanmar. the industry contributes directly to world GDP and supports a high number of employees. Whether you’re from a drug company, healthcare organisation, medical company, industry association, consultancy, financial institution or government, our Nov 23, 2024 · Explore the intricate pharmaceutical regulations in Myanmar, focusing on drug approval processes, manufacturing standards, and the vital roles of the Ministry of Health and Sports and the FDA. 2 Profile of FAME Pharmaceutical Industry Company Myanmar Pharmaceuticals Reports: Our 2025 Myanmar report include trends, statistics, opportunities, sales data, market share, segmentation projections on the Pharmaceuticals market. Despite the small size of Myanmar’s pharmaceutical market, Myanmar offers the pharmaceutical companies or drug-makers strong revenue-earning opportunities. This legislation, which is the main law governing pharmaceuticals in Myanmar, systematically regulates the manufacture, import, export, storage, distribution and sale of drugs in the country. 4 Overview of State-owned Pharmaceutical Factories 25 in Myanmar 3. ,Ltd. txt) or read online for free. It discusses Myanmar's population demographics, GDP, poverty levels and age structure. Apr 1, 2016 · The article provides an industry analysis and the strategies adopted by the Indian Pharmaceutical companies to engineer growth primarily through generics, biosimilars and formulations. DSpace - World Health Organization DSpace 2. “The country’s pharmaceutical industry is fuelled by the growing per capita income The global pharmaceutical market size was estimated at USD 1,645. Initial application for Registration An application for registration of drug must be submitted to the Department of Food and Drug Administration in the original prescribed form ( Form 1 Registration). Feb 1, 2024 · Burma has a very competitive pharmaceutical market compared to other ASEAN countries. It discusses the structure of the Ministry of Health, the mix of modern and traditional medical practices, and the growing role of private healthcare and foreign About Nicholas Hall Group of Companies: An international specialist in OTC consumer healthcare and associated industries, it ofers consultancy, competitive intelligence, market analysis, Merger & Acquisitions, in- an out-licensing, training, and recruitment. Wider competition in pharma manufacturing across the region adds to the mix creating a dynamic environment to which industry players must adapt. The pharmaceutical control system involves the Myanmar Food and Drug Board of Authority, Drug Advisory Committee, and state/regional Food and Drug Supervisory Committees. Navigating regulations: Flemish companies can ensure compliance with Myanmar’s dynamic regulations and import protocols through the collaboration with relevant industry associations and local importers, streamlining the process of introducing their products to the Myanmar market. 1. We take pride in our cGMP compliant facility with necessary infrastructure and experienced technical personnel to manufacture products of reliable quality at affordable prices. 01m. is one of the Myanmar's leading pharmaceutical companies, based in Yangon, with branch offices in Singapore, Mandalay and Mawlamyaing. 39m. These indirect economic effects, as well as the economic effects induced by pr Sandar Myaing Co. It analyzes the company's product range, which includes drugs from A Pharma, B Pharma, and C Pharma. India is one of the highest The global pharma market, excluding vaccines, is expected to reach $2,030 billion by 2027 at a CAGR of ~7%, at constant exchange rates Our Profile Myanmar Pharmaceutical and Medical Device Manufacturer Association (MPMDMA) was established in April 2018 with the permission from the Ministry of Planning and Finance in their announcement letter (SaBa/Si/Khant - 1/1 (3124/2018)) dated 26th April 2018 with the official registration number 187/2018/19 (AhThin). 3 Organizational Structure 19 3. This document summarizes Porter's five forces analysis of the pharmaceutical industry in Myanmar. Definition: Pharmacies are physical or digital places where mainly pharmaceuticals and medical Nov 9, 2016 · MISSION Under the guidance of the Ministry of Health and Sports, supervise the safety, quality and efficacy of food, drug, cosmetic and medical device with strong backbone of laws and international agreements Introduction As Myanmar grasps a market economy, the country is slowly making progress. we are committed to provide a wide variety of pharmaceutical solutions to address the diverse needs of the patients. 10%. The marketing team did market research to assess various pharmaceutical products to meet the healthcare requirements of the target market and to manage customer relationships. 3. 56m in 2025. We are locally owned and operated to ensure consistent and reliable services are provided throughout the distribution chain process management. Effective pharmaceutical marketing goes beyond traditional The document is a study on the marketing mix activities of ABC Trading Co. 0, exploring how the industry grappled with challenges like supply chain disruption, security, and escalating drug manufacturing costs. Generic and over-the-counter drug companies in particular stand to benefit, as the population’s per capita expenditure on pharmaceuticals and healthcare remains low but set to rise WELCOME TO BMI’S PHARMACEUTICALS SERVICE Our in-depth forecasts and analysis are designed to help you navigate risks, identify business opportunities and make beter strategic decisions, particularly in emerging and frontier markets. If there is more investment in manufacturing, pharmaceutical companies will be able to sell their products competitively. This compendium of facts and figures relating to the biopharmaceutical industry and global health aims to provide a snapshot of the work this industry undertakes today. I am proud to introduce the 2022 update of the “Facts & Figures Report”. page 1 Oct 1, 2013 · International pharmaceutical companies are flocking into Myanmar to explore business opportunities in the country. The recent research conducted by one of the local market research agencies states that the spending expenditure of pharmaceuticals market sector of Myanmar has been rising at a rate of 11 percent INDUSTRY CO. 75 billion in 2024 and is projected to reach USD 2,350. pdf), Text File (. Definition: The Over-the-Counter Pharmaceuticals market includes non-prescription medications . Nov 6, 2020 · View Notes - Sarva Pharma Environmental Analysis. In the case of pharmaceutical sector the amendment in Patent Acts in 2005, relaxations in FDI regulations, National Health Policy 2017, etc. Our company markets a number of trusted over-the-counter and prescribed medicine all over Myanmar through our extensive network such as wholesales, retails, government hospitals, polyclinics and clinics Jan 1, 2013 · PDF | ABSTRACT Pharmaceutical industry contributes to the welfare of humanity and provides significant socio-economic benefits to the society through | Find, read and cite all the research you THE PHARMACEUTICAL INDUSTRY: A KEY ASSET TO SCIENTIFIC AND MEDICAL PROGRESS Thanks to advances in science and technology, the research-based pharmaceutical industry is entering an exciting new era in medicines development. A number of major pharmaceutical factories in Myanmar were built by KTECG as turn-key solutions. Amidst these hurdles, 2023 provided a chance for the pharmaceutical supply chain to proactively address issues Find list of pharmaceutical companies and industries in Myanmar offering wide range of pharmaceutical products and medicines. The report also identifies Oct 5, 2023 · Traditional medicines also play a big role in medical treatment in Myanmar, with a vast population of the country relying on traditional medicines for management of diseases. Myanmar: In Myanmar, the Pharmacies market is forecasted to achieve a revenue of US$897. This comprehensive overview will equip Domestic market: is underdeveloped. The county is dependent on imports for all kind of pharmaceutical products which includes prescription-only medicines, over-the-counter medicines and nutraceutical supplements The The report reviews the healthcare system and pharmaceutical market in Myanmar over the last decade, highlighting its rapid growth potential amidst existing challenges such as underinvestment and regulatory hurdles. The formost and largest Pharmaceutical Factory in Myanmar interms of production capacity. (15) 3. This publication examines the most recent available data on biopharmaceutical innovation and global health, access to medicines and healthcare systems 3 hours ago · Myanmar leader Aung San Suu Kyi pulled out of the first event of her election campaign on Monday, citing a worsening outbreak of the novel coronavirus in the country. The pharmaceutical industry is a shining example of the way India can transform economic sectors through appropriate policy interventions for unleashing the power of entrepreneurship. Second, through its economic activity, the global pharmaceutical industry supports additional value creation and employment through its dependence on global supply chains. With around 10 stores from local community pharmacies to large destination health and beauty stores, they will find us in the locations they want us to be, offering fantastic products and services, and will be cared for by expert, friendly people. Utilizing the country’s abundant natural resources, Fame Pharmaceuticals has combined modern and traditional techniques with innovative packaging and eye-catching The document provides an overview of Myanmar's regulatory and pharmaceutical market profile. Learn about challenges faced in the regulatory landscape, penalties for non-compliance, and future directions for improving drug safety and accessibility. Jun 28, 2019 · 8 allopathic manufacturers and 1 government manufacturing unit called Myanmar Pharmaceutical Factory (MPF). Market Overview Country's pharmaceutical market is valued at USD 456 Million in 2017. The pharmaceutical market in Myanmar is mainly depended on the foreign imported medicines and drugs as Myanmar’s domestic pharmaceutical industry is still small. It examines the company's pricing strategies, distribution channels in Yangon, and promotion activities. Myanmar’s pharmaceutical market is estimated to be worth about US$600 million and is expected to grow to $1 billion in the next five years. Additionally, the country`s healthcare infrastructure is INTRODUCTION Thailand's pharmaceutical market will continue on a positive growth trajectory. Myanmar: In 2025, the projected revenue in the Pharmaceuticals market in Myanmar is expected to reach US$283. In recent decades the pharmaceutical market has expanded its geographical reach. 2. have not only contributed immensely over the past years to India’s Myanmar: In 2025, the revenue in the OTC Pharmaceuticals market in Myanmar amounts to US$256. Oct 2, 2013 · Foreign companies zero in on Myanmar with the hope of securing a foothold in its pharmaceutical market. 33 in 2023) Providing Affordable Traditional Medicine Traditional medicine has been used for generations in Myanmar, and recently enacted policies have proven advantageous to help people throughout the country access traditional medicine. Oct 3, 2024 · PDF | Researchers from various fields of scientific knowledge have dedicated efforts to investigate the multiple characteristics of the pharmaceutical | Find, read and cite all the research you A person or company wishing to import pharmaceuticals on a regular basis must first register with Directorate of Trade under the Ministry of Commerce, then apply to Myanmar Food and Drug Authority Board. Local supplies are mainly produced by the state-owned Myanmar Pharmaceutical Factory. who. FairDeal is one of the fastest growing market expansion & distribution companies in Myanmar & Cambodia for Pharmaceuticals, Healthcare and Consumer products. Pharmaceutical Industry being knowledge based and keeping in view of the available opportunities and Indian Pharma industry’s keen enthusiasm to serve the global healthcare industry, Government of India felt the need of an exclusive export promotion council. 5 Growth and Development of Pharmaceutical Production 34 In Myanmar iii About this report This document was drafted by a group of national and international organisations with in depth knowledge and extensive experience of drug-related issues in Myanmar, and was reviewed by several lawyers and international drug policy experts. explores the key strategies employed by pharmaceutical companies in their marketing efforts and the challenges they encounter in this ever-changing environment. int DSpace The white paper by Solidiance discusses the rapidly evolving healthcare landscape in Myanmar, driven by economic growth and increasing healthcare expenditures, which are projected to exceed USD 2 billion for FY 2015-2016. We're here to help our customers look and feel better than they ever thought possible. The market is attracting foreign pharmaceutical companies and is dominated by imports. 3. The authors take the reader through the intricacies of the Act and the institutions and regulatory THE PHARMACEUTICAL INDUSTRY: A KEY ASSET TO SCIENTIFIC AND MEDICAL PROGRESS Thanks to advances in science and technology, the research-based pharmaceutical industry is entering an exciting new era in medicines development. 6Wresearch actively monitors the Myanmar Pharmaceutical Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. A majority of the country's pharmaceutical supplies were imported or produced by the Myanmar Pharmaceutical Factory, the only state-owned pharmaceutical plant in the country under the Mi istry of Industry. It highlights the burgeoning demand for diagnostic imaging and in-vitro diagnostics, noting that while there are significant market opportunities, supply currently lags Import of pharmaceuticals (and other items?) only with proof of export earnings On 28 August 2024, the Department of Trade under the SAC notified the Myanmar Pharmaceutical and Medical Device Manufacturer Association that from 1 September 2024, import licenses for pharmaceuticals may only be granted if the importer can show export earnings, and that old import license applications (among them the Ministry of Health and the Myanmar Food and Drug Board of Authority may issue orders and directives as may be necessary (Sd. Most of pharmaceutical products and drugs are mainly imported from other countries like India, Bangladesh, China, Indonesia, Pakistan, Thailand and Vietnam. Overview Aging populations are transforming pharmaceutical markets in Southeast Asia. BPI (Insein) There are three state-owned Pharmaceutical Factories under the supervision of Myanmar Pharmaceutical Industrial Enterprise, Ministry of Industry. Gross domestic product and life expectancy have both become relentlessly, with compensations, disposable Introduction As Myanmar grasps a market economy, the country is slowly making progress. Pharmaceuticals in Myanmar – Law and Procedure Thida Aye* and James Finch** This article considers the National Drug Law, 1992, of Myanmar or Burma. Department of Traditional Medicine is regulatory authority for traditional medicines. Burma imports about 80 percent of its pharmaceutical products from other countries. Apr 1, 2022 · Myanmar's pharmaceutical market is a very competitive market with high dependence on imported medicines from India, China, Bangladesh, Thailand, Vietnam and Pakistan. The report includes a regional overview and developments. The innovative Products of Pharma Ye' Ta Khon In Pharma Ye’ Ta Khon Co. The marketing manager was an experienced pharmaceutical professional with expertise in three multinational companies. The innovative Jun 2, 2020 · PDF | Pharmaceutical industry in India has made significant positive impact to health care outcomes in India and other developing as well as developed | Find, read and cite all the research you Bringing Brands To Markets In Myanmar & Cambodia. 2 million by 2025, reflecting a 16% growth compared to 2024. 1 Overview of Myanmar Pharmaceutical Industry 21 3. As a well-known company in pharma industry of Myanmar, we have full facilities of required infrastructure for a pharmaceutical company like offices, warehouses, delivery vehicles and distribution networks. It was agreed that the WHO/SEARO workbook tool would be used and that a team of government officials, led by the Essential Drug Program of the Medical Care THET PAING SOE is one of the experienced pharmaceuticals marketing and distribution companies dedicated to the availability of quality pharmaceuticals products in Myanmar. Pharmaceutical Companies and Distributors in Myanmar (Burma) This is the list of pharmaceutical companies and distributors in Myanmar (Burma) with full contact details. Gross domestic product and life expectancy have both become relentlessly, with compensations, disposable The document provides an overview of the healthcare system in Myanmar, highlighting the government's low healthcare budget, which stood at 3. pdf from MBA 1041210461 at Srm Institute Of Management And Technology. Form(1) is available at one thousand kyats each at office of the Department of Food and Drug Administration, Naypyitaw and Yangon. Growing healthcare expenditures bring opportunities for pharma, but change also brings new complexities and challenges. Research methods are evolving and we have many promising prospects on the horizon, with ground-breaking cell and gene therapies being increasingly available*. It outlines the distribution channels, promotional strategies, and the key players in the market, emphasizing the need for new product registrations and local production. This trend appears to be here to stay; in a survey of major pharmaceutical firms conducted by global consulting firm PwC’s Strategy& team, more than half of respondents anticipated that over 30% of their global sales would originate in emerging markets by 2018. With increasing demand for healthcare services, government reforms, and rising disposable incomes, Myanmar's pharmaceutical market is projected to expand, driven primarily by Myanma Pharmaceutical Industrial Enterprise (MPIE; Burmese: မြန်မာ့ဆေးဝါးလုပ်ငန်း) is a state-owned enterprise (SOE) under the Ministry of Industry that conducts R&D, manufacturing and distribution for over 200 essential pharmaceuticals. We are well established in Myanmar and able to cover the whole country from northest Myeik Kyi Na to southest Myeik, and western Sittwe to eastern Lashio. We have a team of qualified scientists and engineers who have sufficient experience in building pharmaceutical production and related facilities. We have helped our partners build successful brands in Myanmar since 2008 and have continually invested in our people, processes, technology and services to be the pioneer in the market expansion services for healthcare and consumer goods sector The Pharmaceutical companies in Myanmar are thriving from $600 million in 2016, and estimates are made that this number will almost double to over $1 billion by 2023, which explains the premise of this industry. The pharmaceutical industry is experiencing rapid transformations in response to dynamic market conditions, technological advancements, and evolving regulatory landscapes. 2. 9% in 2013, and the high reliance on out-of-pocket expenses for healthcare spending. , Ltd, a pharmaceutical trading company in Myanmar. Myanmar Pharma market - Free download as PDF File (. INTRODUCTION Myanmar is a country with very limited own pharmaceutical production. 43 billion by 2030, growing at a CAGR of 6. India is the top importer of pharmaceutical formulations to Myanmar, making up 34% of The DFDA is responsible for regulating drugs through registration, manufacturing and import licensing, inspections, post-market surveillance, and adverse drug reaction monitoring. 1 billion by 2023, growing at 11% annually. )Than Shwe General Chairman The State Law and Order Restoration Council Jun 24, 2019 · With new facilities, imported equipment and foreign expertise, a state-owned enterprise is expanding its pharmaceutical business – and even moving into export markets. Dec 13, 2023 · In this webinar David Mol, a Senior Associate in Tilleke & Gibbins’ Cambodia office, Dino Santaniello, Head of Tilleke & Gibbins’ Laos office, and Yuwadee Thean-ngarm and Aye Thuzar Hlaing, Director and Senior Associate in Tilleke & Gibbins’ Myanmar office, will provide an overview of the regulatory framework for the importation of pharmaceutical products in their three countries THET PAING SOE is one of the experienced pharmaceuticals marketing and distribution companies dedicated to the availability of quality pharmaceuticals products in Myanmar. Nicholas Hall’s unique DB6 Global OTC Database provides the most comprehensive sales data specifically for the OTC industry. This value is lower than that of most of the ASEAN countries, placing Myanmar below even Singapore in terms of absolute pharmaceutical market size, despite its much larger population (60mn versus 5mn). Zifam Myanmar becomes one of the leading, fast growing and a professionally managed pharmaceutical marketing company in Myanmar. This document provides an overview of the Myanmar pharmaceutical market, including key statistics such as the estimated $100-120 million market size and leading import countries. However, comparatively the low levels of affordability and poor access to healthcare, the market will mainly be the government of Myanmar to become a more efective regulator. , Ltd. ,Ltd is the leading distribution company in Myanmar specializing in pharmaceutical and consumer products situated in Yangon, Myanmar. The study uses interviews and secondary data to understand ABC INTRODUCTION The Association of Southeast Asian Nations (ASEAN) contains the following 10 countries like Indonesia, Malaysia, Philippines, Singapore, Thailand, Brunei Darussalam, Vietnam, Laos, Myanmar and Cambodia was establish in 1967 to promote pharmaceutical market in ASEAN countries. CDE Guidelines for Cell and Gene Therapy Drugs CDE Notice on Issuing the Technical Guidelines for Pharmaceutical Research and Evaluation of Human-derived Stem Cell Products(Trial)(No. To achieve this, Myanmar should consider (a) unbundling policy, regulatory, and delivery functions of the MOTC; (b) creating an independent regulator in telecommunications; (c) improving the capacity of financial regulators; (d) adopting regulations on infrastructure sharing The market in India Any perspective on Asia that does not mention India would be incomplete. 2 Overview of Myanmar Pharmaceutical Industry 19 3. Notable challenges include accessing imports The 2023 CPHI Online Pharma Trends Report delved into critical issues, from reshoring drug production to manufacturing reimagined through Pharma 4. It discusses the forces of rivalry, risk of new entry, bargaining power of buyers and suppliers, and potential substitutes. Introduction A situational analysis was conducted in Myanmar during 13-23 October 2014. Myanmar’s pharmaceutical market has attracted investors with the sector projected to be worth $100 to $120 million despite its relatively small population of approximately 60 million people. , LTD 21 3. It provides a thorough analysis of the draft bill amending Myanmar 1993 Narcotic Drugs and Psychotropic Substances Law, in the light of UN PMI is a pioneer in the Myanmar pharmaceutical manufacturing enviroment of quality branded and generic drugs supported by innovations from a strong international R&D team. The pharmaceutical market size was $456 million in 2017 and is expected to reach $1. This report on the Availability and Pricing of Essential Medicines in Myanmar relies on multiple assessments (2021 - 2023) conducted jointly by the World Bank and World . For these MC activities, the legislation, and regulations The Myanmar pharmaceutical market faces several challenges, including inadequate healthcare infrastructure, limited access to healthcare services in rural areas, low healthcare spending, lack of regulatory framework and enforcement, counterfeit drugs, and reliance on imported pharmaceutical products. The pharmaceutical market in Myanmar is very competitive, and the country imports 80% of pharmaceutical goods from other nations. Definition: The Pharmaceuticals market covers remedies used to cure, treat I. Jan 23, 2017 · PDF | This report intends to consolidate the main developments of the pharmaceutical market in Myanmar over the last decade. Western countries companies are now beginning to show some inte The document provides an overview of Myanmar's pharmaceutical market, highlighting its geographical context, market size, and the dominance of imported products, particularly from Indian companies. Apr 21, 2025 · This market-based pricing method aims to balance affordability for consumers with the sustainability of the pharmaceutical industry by reflecting prevailing market conditions. Efforts are being made to reform regulatory processes for innovative drug registrations helping Thailand to attract greater foreign investment into its domestic pharmaceutical industry. 8tk iz homburp adluz maw5b dbac7 eslv7 wbe cwyr kwyug